M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3

Abstract Metastasis is the most prevalent cause of cancer deaths, and immunological components of the tumor microenvironment, especially tumor‐associated macrophages (TAMs), play a vital role in cancer metastasis. However, the underlying mechanisms of TAMs on non‐small‐cell lung cancer (NSCLC) metas...

Full description

Bibliographic Details
Main Authors: Lamei Huang, Fang Wang, Xueping Wang, Chaoyue Su, Shaocong Wu, Chuan Yang, Min Luo, Jianye Zhang, Liwu Fu
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.191
_version_ 1811166310732660736
author Lamei Huang
Fang Wang
Xueping Wang
Chaoyue Su
Shaocong Wu
Chuan Yang
Min Luo
Jianye Zhang
Liwu Fu
author_facet Lamei Huang
Fang Wang
Xueping Wang
Chaoyue Su
Shaocong Wu
Chuan Yang
Min Luo
Jianye Zhang
Liwu Fu
author_sort Lamei Huang
collection DOAJ
description Abstract Metastasis is the most prevalent cause of cancer deaths, and immunological components of the tumor microenvironment, especially tumor‐associated macrophages (TAMs), play a vital role in cancer metastasis. However, the underlying mechanisms of TAMs on non‐small‐cell lung cancer (NSCLC) metastasis remain largely unexplored. Herein, we demonstrated that M2‐like TAMs facilitate the migration and invasion of cancer cells in vitro and in vivo through intercellular delivery of M2‐like macrophage‐derived exosomes (M2‐exos). Importantly, we found that M2‐exos had considerably higher levels of integrin (ITG) αV and β3. The impact of M2‐like macrophage‐mediated invasion and migration of NSCLC cells was clearly decreased when ITG αVβ3 was blocked. Mechanistically, exosomal ITG αVβ3 produced from M2‐like macrophages successfully triggered the focal adhesion kinase signaling pathway in recipient cells, boosting the migratory and invasive abilities of NSCLC cells. Clinically, we found that metastatic NSCLC patients had greater ITG αV and β3 expression, which was associated with a worse prognosis. This study reveals a novel mechanism by which M2‐exos significantly increased NSCLC cell migration and invasion by delivering integrin αVβ3. Exosomal ITG αVβ3 can be used as a potential prognostic marker, and blocking ITG αVβ3 could be a viable treatment option for preventing tumor metastasis.
first_indexed 2024-04-10T15:50:19Z
format Article
id doaj.art-1a1adec3a81541f089c536db0cec16bd
institution Directory Open Access Journal
issn 2688-2663
language English
last_indexed 2024-04-10T15:50:19Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series MedComm
spelling doaj.art-1a1adec3a81541f089c536db0cec16bd2023-02-11T14:06:29ZengWileyMedComm2688-26632023-02-0141n/an/a10.1002/mco2.191M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3Lamei Huang0Fang Wang1Xueping Wang2Chaoyue Su3Shaocong Wu4Chuan Yang5Min Luo6Jianye Zhang7Liwu Fu8State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology NMPA and State Key Laboratory of Respiratory Disease School of Pharmaceutical Sciences and the Fifth Affiliated Hospital Guangzhou Medical University Guangzhou P. R. ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology NMPA and State Key Laboratory of Respiratory Disease School of Pharmaceutical Sciences and the Fifth Affiliated Hospital Guangzhou Medical University Guangzhou P. R. ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Esophageal Cancer Institute Sun Yat‐sen University Cancer Center Guangzhou P. R. ChinaAbstract Metastasis is the most prevalent cause of cancer deaths, and immunological components of the tumor microenvironment, especially tumor‐associated macrophages (TAMs), play a vital role in cancer metastasis. However, the underlying mechanisms of TAMs on non‐small‐cell lung cancer (NSCLC) metastasis remain largely unexplored. Herein, we demonstrated that M2‐like TAMs facilitate the migration and invasion of cancer cells in vitro and in vivo through intercellular delivery of M2‐like macrophage‐derived exosomes (M2‐exos). Importantly, we found that M2‐exos had considerably higher levels of integrin (ITG) αV and β3. The impact of M2‐like macrophage‐mediated invasion and migration of NSCLC cells was clearly decreased when ITG αVβ3 was blocked. Mechanistically, exosomal ITG αVβ3 produced from M2‐like macrophages successfully triggered the focal adhesion kinase signaling pathway in recipient cells, boosting the migratory and invasive abilities of NSCLC cells. Clinically, we found that metastatic NSCLC patients had greater ITG αV and β3 expression, which was associated with a worse prognosis. This study reveals a novel mechanism by which M2‐exos significantly increased NSCLC cell migration and invasion by delivering integrin αVβ3. Exosomal ITG αVβ3 can be used as a potential prognostic marker, and blocking ITG αVβ3 could be a viable treatment option for preventing tumor metastasis.https://doi.org/10.1002/mco2.191exosomesintegrin αVβ3M2‐like macrophagemetastasisNSCLC
spellingShingle Lamei Huang
Fang Wang
Xueping Wang
Chaoyue Su
Shaocong Wu
Chuan Yang
Min Luo
Jianye Zhang
Liwu Fu
M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
MedComm
exosomes
integrin αVβ3
M2‐like macrophage
metastasis
NSCLC
title M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
title_full M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
title_fullStr M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
title_full_unstemmed M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
title_short M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
title_sort m2 like macrophage derived exosomes facilitate metastasis in non small cell lung cancer by delivering integrin αvβ3
topic exosomes
integrin αVβ3
M2‐like macrophage
metastasis
NSCLC
url https://doi.org/10.1002/mco2.191
work_keys_str_mv AT lameihuang m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT fangwang m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT xuepingwang m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT chaoyuesu m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT shaocongwu m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT chuanyang m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT minluo m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT jianyezhang m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3
AT liwufu m2likemacrophagederivedexosomesfacilitatemetastasisinnonsmallcelllungcancerbydeliveringintegrinavb3